These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 31349150)

  • 1. Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers.
    Bucerius SM; Haggerty KD
    Int J Drug Policy; 2019 Sep; 71():133-138. PubMed ID: 31349150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-related deaths in Ontario correctional facilities and penitentiaries (2009-2019).
    Button L; Williams AS; Lamparter C; Woodall KL
    Forensic Sci Med Pathol; 2023 Sep; 19(3):357-363. PubMed ID: 36690802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random mandatory drugs testing of prisoners: a biassed means of gathering information.
    Gore SM; Bird AG; Strang JS
    J Epidemiol Biostat; 1999; 4(1):3-9. PubMed ID: 10613711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of Toxic Adulterants in Street Drugs in the US Illicit Opioid Crisis.
    Singh VM; Browne T; Montgomery J
    Public Health Rep; 2020 Jan; 135(1):6-10. PubMed ID: 31738861
    [No Abstract]   [Full Text] [Related]  

  • 5. A mapping review of take-home naloxone for people released from correctional settings.
    Horton M; McDonald R; Green TC; Nielsen S; Strang J; Degenhardt L; Larney S
    Int J Drug Policy; 2017 Aug; 46():7-16. PubMed ID: 28575724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing prescription opioid, heroin, and fentanyl initiation trajectories: A qualitative study.
    Perdue T; Carlson R; Daniulaityte R; Silverstein SM; Bluthenthal RN; Valdez A; Cepeda A
    Soc Sci Med; 2024 Jan; 340():116441. PubMed ID: 38061222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.
    Mayer S; Boyd J; Collins A; Kennedy MC; Fairbairn N; McNeil R
    Drug Alcohol Depend; 2018 Dec; 193():69-74. PubMed ID: 30343236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.
    Slavova S; Costich JF; Bunn TL; Luu H; Singleton M; Hargrove SL; Triplett JS; Quesinberry D; Ralston W; Ingram V
    Int J Drug Policy; 2017 Aug; 46():120-129. PubMed ID: 28735777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal overdoses after release from prison in British Columbia: a retrospective data linkage study.
    Kinner SA; Gan W; Slaunwhite A
    CMAJ Open; 2021; 9(3):E907-E914. PubMed ID: 34584005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing traceable opioid material
    Mojica MA; Carter MD; Isenberg SL; Pirkle JL; Hamelin EI; Shaner RL; Seymour C; Sheppard CI; Baldwin GT; Johnson RC
    Toxicol Lett; 2019 Dec; 317():53-58. PubMed ID: 31560942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD.
    Park JN; Weir BW; Allen ST; Chaulk P; Sherman SG
    Harm Reduct J; 2018 Jul; 15(1):34. PubMed ID: 29976195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring prison buprenorphine misuse in the United Kingdom: a qualitative study of former prisoners.
    Tompkins CN; Wright NM; Waterman MG; Sheard L
    Int J Prison Health; 2009; 5(2):71-87. PubMed ID: 25759139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
    Weitzman ER; Kossowsky J; Blakemore LM; Cox R; Dowling DJ; Levy O; Needles EW; Levy S
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S98-S109. PubMed ID: 35579508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.
    Silverstein SM; Daniulaityte R; Martins SS; Miller SC; Carlson RG
    Int J Drug Policy; 2019 Dec; 74():76-83. PubMed ID: 31563098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
    Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
    Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Prison facilities were not built with a woman in mind': an exploratory multi-stakeholder study on women's situation in Malawi prisons.
    Gadama L; Thakwalakwa C; Mula C; Mhango V; Banda C; Kewley S; Hillis A; Van Hout MC
    Int J Prison Health; 2020 Apr; 16(3):303-318. PubMed ID: 33634658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Burnout and victimisation: impact of inmates' aggression towards prison guards].
    Boudoukha AH; Hautekeete M; Abdellaoui S; Groux W; Garay D
    Encephale; 2011 Sep; 37(4):284-92. PubMed ID: 21981889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.